Ezra M. Friedberg serves as Executive at Chromocell Therapeutics Corp, where they oversee executive responsibilities. Since joining the company, Ezra M. Friedberg has executed 9 insider transactions totaling $380.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 25, 2025 involved selling 2,000 shares valued at $56.3K.
Ezra M. Friedberg currently holds 32,001 shares of Chromocell Therapeutics Corp (CHRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ezra M. Friedberg has been a net seller of CHRO stock. They have purchased $100.0K and sold $280.3K worth of shares.
Ezra M. Friedberg's most recent insider trade was on Nov 25, 2025, when they sold 2,000 shares at $28.14 per share.
Get notified when new Form 4 filings are submitted
| $28.50 |
| Discretionary |
| Nov 25, 2025 | PTHS | $56.0K | Sale | 2,000 | $28.01 | Discretionary |
| Nov 25, 2025 | PTHS | $168.0K | Sale | 5,999 | $28.00 | Discretionary |
| Jul 1, 2025 | PTHS | $400.0K | Conversion | 40,000 | $10.00 | Discretionary |
| Jul 1, 2025 | PTHS | $400.0K | Conversion | 40,000 | $10.00 | Discretionary |
| Feb 21, 2024 | CHRO | $33.6K | Option Exercise | 6,992 | $4.80 | Discretionary |
| Feb 21, 2024 | CHRO | $65.5K | Option Exercise | 13,649 | $4.80 | Discretionary |
| Feb 21, 2024 | CHRO | $100.0K | Purchase | 16,667 | $6.00 | Discretionary |